pharma : Latest News, Videos and Photos | Outlook Business
Story of the day
Home » Search
Search Result : "pharma"

The pharma index has hugely underperformed the Sensex in CY17 owing to regulatory overhang and FDA issues 

Nilesh Shetty and Anand Shah on whether pharma stocks can make a comeback

Even as the tax holiday comes to an end, businesses in Pantnagar say better infrastructure will drive future investments and sustain the growth momentum

Business is looking up in Nashik and Aurangabad, but labour issues — rising costs, shortage of skilled workers and unionisation — continue to play spoilsport

Even as the rest of the country grappled with GST, the Naroda cluster wasted no time in getting back on track 

Businesses across the country’s industrial clusters are optimistic about FY19

Rising chronic illnesses and increasing health insurance coverage will spur domestic pharma industry growth

The Indian pharma industry has a stellar decadal run and it’s not going to change anytime soon

Banking on acquisitions, Torrent Pharma is focused on strengthening its presence in the domestic market

For Radhe Shyam Agarwal & Radhe Shyam Goenka, Emami still remains their best investment

Simulanis uses augmented and virtual reality with gamification to make training fun for students and employees

A strong product pipeline and receding US FDA threat could well turn the tide in favour of the beleaguered pharma players

While markets seem to be betting on a better-than expected earnings season, the numbers tell a different story

Lupin is betting on its specialty drugs business to counter the pricing pressures in the US generics market 

His bet on Natco Pharma’s differentiated product portfolio paid off while Monnet Ispat taught him to be wary of over-ambitious entrepreneurs

Bharat Shah successfully vetted Bajaj Finance, but overvalued and misjudged Visualsoft

What makes Intas the most valuable privately-held pharma company in India

Outstanding companies that exemplify the power of Indian enterprise

Promoter Desh Bandhu Gupta buys 88,000 shares from the market as Lupin trades near its 52-week low

The domestic pharma industry, which is already battling the US FDA, has now to contend with regulatory challenges at home

Even as it battles the US FDA, the industry has been caught off-guard by policy changes back home

Regulatory woes continue to pile up for pharma companies

For Ajay Garg, investing is a 24/7 activity, even when he is out shopping 

Textile and Pharma companies in Ahmedabad want clarity and stability in policy framework even as they battle short-term hiccups caused by demonetisation 

Shankar Sharma of First Global feels it’s time to cut out the noise and look for some real opportunities

The recent negative news flow has led to a selling spree in Aurobindo Pharma

On Stands Now